Ion channel modulating agents
AssigneeNeuroSearch A/S
InventorsBo Skaaning Jensen, Palle Christophersen, Dorte Strobaek, Lene Teuber
Life of this patent
Estimating the term…
Abstract
The present invention relates to ion channel modulating agents. More particularly, the present invention relates to a particular class of oxime derivatives represented by general formula (I) that has proven useful as modulators of SKCa, IKCa and BKCa channels. In further aspects, the present invention relates to the use of these SK/IK/BK channel modulating agents for the manufacture of medicaments, and pharmaceutical compositions comprising the SK/IK/BK channel modulating agents. The SK/IK/BK channel modulating agents of the invention are useful for the treatment or alleviation of diseases and conditions associated with the SK/IK/BK channels. 1
Claims15
An oxime derivative represented by the general formula
- 13
- or a pharmaceutically acceptable salt or an oxide or a hydrate thereof, wherein,
- X represents oxygen, sulphur, or an amino group, preferably an amino group of the formula NHR3;
- R1 represents hydrogen;
- an alkyl group;
- a cycloalkyl group;
- hydroxy;
- an alkoxy group;
- an acyl group;
- a phenyl or a benzyl group, which phenyl and benzyl groups may be substituted one or more times with substituents selected from halogen, —NO2, —CN, —CF3, alkyl, cycloalkyl, hydroxy, and alkoxy;
- a group of the formula —CH2CN;
- a group of the formula —CH2CO2R′, wherein R′ represents hydrogen or an alkyl group;
- a group of the formula —CH2CONRIVRV, wherein RIV and RV independently represents hydrogen or an alkyl group;
- or a group of the formula —CH2C(═NOH)NH2;
- R2 represents hydrogen, an alkyl group, a cycloalkyl group, a phenyl or a benzyl group, which phenyl and benzyl groups may be substituted one or more times with substituents selected from halogen, —NO2, —CN, —CF3, alkyl, cycloalkyl, hydroxy, and alkoxy;
- R3 represents hydrogen, an alkyl group, a cycloalkyl group, a phenyl or a benzyl group, which phenyl and benzyl groups may be substituted one or more times with substituents selected from halogen, —NO2, —CN, —CF3, alkyl, cycloalkyl, hydroxy, and alkoxy;
- and
- R4 and R5, independently of each another represents hydrogen;
- halogen;
- —NO2;
- —CN;
- —CF3;
- an alkyl group;
- an alkoxy group;
- a phenyl or a benzyl group, which phenyl and benzyl groups may be substituted one or more times with substituents selected from halogen, —NO2, —CN, —CF3, alkyl, cycloalkyl, hydroxy, and alkoxy, or a group of the formula —SO2NR″R′″, wherein R″ and R′″ independently of each another represents hydrogen or an alkyl group;
- or R4 and R5 together form an additional 4 to 7 membered fused ring, which fused ring may be aromatic or partially saturated, and which fused ring may optionally be substituted one or more times with substituents selected from the group consisting of halogen, —NO2, —CN, —CF3, and a group of the formula —SO2NR″R′″, wherein R″ and R′″ independently of each another represents hydrogen or an alkyl group.
The oxime derivative according to any of claims 14, wherein R4 and R5, independently of each another represents hydrogen, halogen, alkyl, or alkoxy.
The oxime derivative according to any of claims 14, wherein R4 and R5 together form an additional 6 membered fused ring, which fused ring may be aromatic or partially saturated, and which fused ring may optionally be substituted one or more times with substituents selected from the group consisting of halogen, —NO2, —CN, —CF3, and a group of the formula —SO2NR″R′″, wherein R″ and R′″ independently of each another represents hydrogen or an alkyl group.
The oxime derivative according to 6, wherein the oxime derivative is represented by the general formula
- 15
- or a pharmaceutically acceptable salt or an oxide or a hydrate thereof, wherein,
- X, R1, R2 and R3 are as defined above;
- and
- Y represents hydrogen, halogen, —NO2, —CN, —CF3, or a group of the formula —SO2NR″R′″, wherein R″ and R′″ independently of each another represents hydrogen or an alkyl group.
Dependencies are inferred from the claim text.